APO Research

APO RESEARCH · REPORT

Organic Infant Formula

Organic infant formula is uses the finest organic ingredients in milk, which means no chemical pesticides and no GM ingredients.

Product & engineering

Understand the product.

Organic infant formula is uses the finest organic ingredients in milk, which means no chemical pesticides and no GM ingredients.

Organic farming is a method of production that is concerned with respecting natural balances. It is committed to sustainable management, respecting natural balances and biodiversity, and producing high quality products in a way that is not harmful to the environment or health.

Selected research

Market Structure

Global Organic Infant Formula Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

Organic infant formula is uses the finest organic ingredients in milk, which means no chemical pesticides and no GM ingredients.

Organic farming is a method of production that is concerned with respecting natural balances. It is committed to sustainable management, respecting natural balances and biodiversity, and producing high quality products in a way that is not harmful to the environment or health.

At present, the major manufacturers of organic infant formula are Abbott, HiPP, Holle, Bellamy, Topfer, etc. Abbott is the world leader, holding 21% consumption market share. Europe is the largest market, with a share about 52%, followed by Asia Pacific and North America with the share both about 22%.

Read the full market overview

This report provides an overview of the global Organic Infant Formula market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Organic Infant Formula and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Organic Infant Formula sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Organic Infant Formula market size, projected growth trends, production technologies, key applications, and end-use industries.

Organic Infant Formula Segment by Company

Abbott

HiPP

Holle

Bellamy

Topfer

Supermum

The Hain Celestial Group

Nature One

Perrigo

Babybio

Gittis

Humana

Bimbosan

Ausnutria

Nutribio

HealthyTimes

Arla

Angisland

Yeeper

Wyeth

Kendamil

Nestle

Feihe

JUNLEBAO

YILI

BIOSTIME

Biobim

Organic Infant Formula Segment by Type

Wet Process Type

Dry Process Type

Others

Organic Infant Formula Segment by Application

First Stage

Second Stage

Third Stage

Organic Infant Formula Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Organic Infant Formula market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Organic Infant Formula and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Organic Infant Formula.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Organic Infant Formula market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Organic Infant Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Organic Infant Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Organic Infant Formula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Organic Infant Formula Industry Trends Table 2. Organic Infant Formula Industry Drivers Table 3. Organic Infant Formula Industry Opportunities and Challenges Table 4. Organic Infant Formula Industry Restraints Table 5. Global Organic Infant Formula Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Organic Infant Formula Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Organic Infant Formula Sales by Manufacturers (MT) & (2021-2026) Table 8. Global Organic Infant Formula Sales Market Share by Manufacturers Table 9. Global Organic Infant Formula Average Sales Price (USD/MT) of Manufacturers (2021-2026) Table 10. Global Organic Infant Formula Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Organic Infant Formula Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Organic Infant Formula Manufacturers, Product Type & Application Table 13. Global Organic Infant Formula Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Organic Infant Formula by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Wet Process Type Table 17. Major Manufacturers of Dry Process Type Table 18. Major Manufacturers of Others Table 19. Global Organic Infant Formula Sales by Type 2021 VS 2025 VS 2032 (MT) Table 20. Global Organic Infant Formula Sales by Type (2021-2026) & (MT) Table 21. Global Organic Infant Formula Sales by Type (2027-2032) & (MT) Table 22. Global Organic Infant Formula Sales Market Share by Type (2021-2026) Table 23. Global Organic Infant Formula Sales Market Share by Type (2027-2032) Table 24. Global Organic Infant Formula Revenue by Type 2021 VS 2025 VS 2032 (MT) Table 25. Global Organic Infant Formula Revenue by Type (2021-2026) & (MT) Table 26. Global Organic Infant Formula Revenue by Type (2027-2032) & (MT) Table 27. Global Organic Infant Formula Revenue Market Share by Type (2021-2026) Table 28. Global Organic Infant Formula Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of First Stage Table 30. Major Manufacturers of Second Stage Table 31. Major Manufacturers of Third Stage Table 32. Global Organic Infant Formula Sales by Application 2021 VS 2025 VS 2032 (MT) Table 33. Global Organic Infant Formula Sales by Application (2021-2026) & (MT) Table 34. Global Organic Infant Formula Sales by Application (2027-2032) & (MT) Table 35. Global Organic Infant Formula Sales Market Share by Application (2021-2026) Table 36. Global Organic Infant Formula Sales Market Share by Application (2027-2032) Table 37. Global Organic Infant Formula Revenue by Application 2021 VS 2025 VS 2032 (MT) Table 38. Global Organic Infant Formula Revenue by Application (2021-2026) & (MT) Table 39. Global Organic Infant Formula Revenue by Application (2027-2032) & (MT) Table 40. Global Organic Infant Formula Revenue Market Share by Application (2021-2026) Table 41. Global Organic Infant Formula Revenue Market Share by Application (2027-2032) Table 42. Global Organic Infant Formula Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 43. Global Organic Infant Formula Sales by Region (2021-2026) & (MT) Table 44. Global Organic Infant Formula Sales Market Share by Region (2021-2026) Table 45. Global Organic Infant Formula Sales Forecasted by Region (2027-2032) & (MT) Table 46. Global Organic Infant Formula Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Organic Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 48. North America Organic Infant Formula Sales by Country (2021-2026) & (MT) Table 49. North America Organic Infant Formula Sales by Country (2027-2032) & (MT) Table 50. Europe Organic Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 51. Europe Organic Infant Formula Sales by Country (2021-2026) & (MT) Table 52. Europe Organic Infant Formula Sales by Country (2027-2032) & (MT) Table 53. Asia Pacific Organic Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 54. Asia Pacific Organic Infant Formula Sales by Country (2021-2026) & (MT) Table 55. Asia Pacific Organic Infant Formula Sales by Country (2027-2032) & (MT) Table 56. South America, Middle East and Africa Organic Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (MT) Table 57. South America, Middle East and Africa Organic Infant Formula Sales by Country (2021-2026) & (MT) Table 58. South America, Middle East and Africa Organic Infant Formula Sales by Country (2027-2032) & (MT) Table 59. Global Organic Infant Formula Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Organic Infant Formula Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Organic Infant Formula Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Organic Infant Formula Revenue Market Share by Region (2021-2026) Table 63. Global Organic Infant Formula Revenue Market Share by Region (2027-2032) Table 64. Abbott Company Information Table 65. Abbott Business Overview Table 66. Abbott Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Abbott Organic Infant Formula Product Portfolio Table 68. Abbott Recent Development Table 69. HiPP Company Information Table 70. HiPP Business Overview Table 71. HiPP Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. HiPP Organic Infant Formula Product Portfolio Table 73. HiPP Recent Development Table 74. Holle Company Information Table 75. Holle Business Overview Table 76. Holle Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Holle Organic Infant Formula Product Portfolio Table 78. Holle Recent Development Table 79. Bellamy Company Information Table 80. Bellamy Business Overview Table 81. Bellamy Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Bellamy Organic Infant Formula Product Portfolio Table 83. Bellamy Recent Development Table 84. Topfer Company Information Table 85. Topfer Business Overview Table 86. Topfer Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Topfer Organic Infant Formula Product Portfolio Table 88. Topfer Recent Development Table 89. Supermum Company Information Table 90. Supermum Business Overview Table 91. Supermum Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Supermum Organic Infant Formula Product Portfolio Table 93. Supermum Recent Development Table 94. The Hain Celestial Group Company Information Table 95. The Hain Celestial Group Business Overview Table 96. The Hain Celestial Group Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. The Hain Celestial Group Organic Infant Formula Product Portfolio Table 98. The Hain Celestial Group Recent Development Table 99. Nature One Company Information Table 100. Nature One Business Overview Table 101. Nature One Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Nature One Organic Infant Formula Product Portfolio Table 103. Nature One Recent Development Table 104. Perrigo Company Information Table 105. Perrigo Business Overview Table 106. Perrigo Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Perrigo Organic Infant Formula Product Portfolio Table 108. Perrigo Recent Development Table 109. Babybio Company Information Table 110. Babybio Business Overview Table 111. Babybio Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Babybio Organic Infant Formula Product Portfolio Table 113. Babybio Recent Development Table 114. Gittis Company Information Table 115. Gittis Business Overview Table 116. Gittis Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Gittis Organic Infant Formula Product Portfolio Table 118. Gittis Recent Development Table 119. Humana Company Information Table 120. Humana Business Overview Table 121. Humana Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Humana Organic Infant Formula Product Portfolio Table 123. Humana Recent Development Table 124. Bimbosan Company Information Table 125. Bimbosan Business Overview Table 126. Bimbosan Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Bimbosan Organic Infant Formula Product Portfolio Table 128. Bimbosan Recent Development Table 129. Ausnutria Company Information Table 130. Ausnutria Business Overview Table 131. Ausnutria Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Ausnutria Organic Infant Formula Product Portfolio Table 133. Ausnutria Recent Development Table 134. Nutribio Company Information Table 135. Nutribio Business Overview Table 136. Nutribio Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Nutribio Organic Infant Formula Product Portfolio Table 138. Nutribio Recent Development Table 139. HealthyTimes Company Information Table 140. HealthyTimes Business Overview Table 141. HealthyTimes Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. HealthyTimes Organic Infant Formula Product Portfolio Table 143. HealthyTimes Recent Development Table 144. Arla Company Information Table 145. Arla Business Overview Table 146. Arla Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Arla Organic Infant Formula Product Portfolio Table 148. Arla Recent Development Table 149. Angisland Company Information Table 150. Angisland Business Overview Table 151. Angisland Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Angisland Organic Infant Formula Product Portfolio Table 153. Angisland Recent Development Table 154. Yeeper Company Information Table 155. Yeeper Business Overview Table 156. Yeeper Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. Yeeper Organic Infant Formula Product Portfolio Table 158. Yeeper Recent Development Table 159. Wyeth Company Information Table 160. Wyeth Business Overview Table 161. Wyeth Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 162. Wyeth Organic Infant Formula Product Portfolio Table 163. Wyeth Recent Development Table 164. Kendamil Company Information Table 165. Kendamil Business Overview Table 166. Kendamil Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 167. Kendamil Organic Infant Formula Product Portfolio Table 168. Kendamil Recent Development Table 169. Nestle Company Information Table 170. Nestle Business Overview Table 171. Nestle Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 172. Nestle Organic Infant Formula Product Portfolio Table 173. Nestle Recent Development Table 174. Feihe Company Information Table 175. Feihe Business Overview Table 176. Feihe Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 177. Feihe Organic Infant Formula Product Portfolio Table 178. Feihe Recent Development Table 179. JUNLEBAO Company Information Table 180. JUNLEBAO Business Overview Table 181. JUNLEBAO Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 182. JUNLEBAO Organic Infant Formula Product Portfolio Table 183. JUNLEBAO Recent Development Table 184. YILI Company Information Table 185. YILI Business Overview Table 186. YILI Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 187. YILI Organic Infant Formula Product Portfolio Table 188. YILI Recent Development Table 189. BIOSTIME Company Information Table 190. BIOSTIME Business Overview Table 191. BIOSTIME Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 192. BIOSTIME Organic Infant Formula Product Portfolio Table 193. BIOSTIME Recent Development Table 194. Biobim Company Information Table 195. Biobim Business Overview Table 196. Biobim Organic Infant Formula Sales (MT), Price (USD/MT), Revenue (US$ Million) and Gross Margin (2021-2026) Table 197. Biobim Organic Infant Formula Product Portfolio Table 198. Biobim Recent Development Table 199. Key Raw Materials Table 200. Raw Materials Key Suppliers Table 201. Organic Infant Formula Distributors List Table 202. Organic Infant Formula Customers List Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources Table 206. Primary Sources List of Figures Figure 1. Organic Infant Formula Product Image Figure 2. Global Organic Infant Formula Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Organic Infant Formula Market Size (2021-2032) & (US$ Million) Figure 4. Global Organic Infant Formula Sales (2021-2032) & (MT) Figure 5. Global Organic Infant Formula Average Price (USD/MT) & (2021-2032) Figure 6. Global Top 5 and 10 Organic Infant Formula Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Wet Process Type Image Figure 9. Dry Process Type Image Figure 10. Others Image Figure 11. Global Organic Infant Formula Sales by Type (2021 VS 2025 VS 2032) & (MT) Figure 12. Global Organic Infant Formula Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Organic Infant Formula Sales Market Share by Type (2021-2032) Figure 14. Global Organic Infant Formula Revenue by Type (2021 VS 2025 VS 2032) & (MT) Figure 15. Global Organic Infant Formula Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Organic Infant Formula Revenue Market Share by Type (2021-2032) Figure 17. First Stage Image Figure 18. Second Stage Image Figure 19. Third Stage Image Figure 20. Global Organic Infant Formula Sales by Application (2021 VS 2025 VS 2032) & (MT) Figure 21. Global Organic Infant Formula Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Organic Infant Formula Sales Market Share by Application (2021-2032) Figure 23. Global Organic Infant Formula Revenue by Application (2021 VS 2025 VS 2032) & (MT) Figure 24. Global Organic Infant Formula Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Organic Infant Formula Revenue Market Share by Application (2021-2032) Figure 26. North America Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 27. North America Organic Infant Formula Sales Market Share by Country (2021-2032) Figure 28. U.S. Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 29. Canada Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 30. Mexico Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 31. Europe Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 32. Europe Organic Infant Formula Sales Market Share by Country (2021-2032) Figure 33. Germany Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 34. France Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 35. U.K. Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 36. Italy Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 37. Netherlands Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 38. Asia Pacific Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 39. Asia Pacific Organic Infant Formula Sales Market Share by Country (2021-2032) Figure 40. China Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 41. Japan Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 42. South Korea Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 43. Southeast Asia Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 44. India Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 45. Australia Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 46. South America, Middle East and Africa Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 47. South America, Middle East and Africa Organic Infant Formula Sales Market Share by Country (2021-2032) Figure 48. Brazil Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 49. South Africa Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 50. Saudi Arabia Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 51. Turkey Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 52. Argentina Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 53. UAE Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 54. Egypt Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 55. Chile Organic Infant Formula Sales and Growth Rate (2021-2032) & (MT) Figure 56. Global Organic Infant Formula Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Organic Infant Formula Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Organic Infant Formula Revenue (2021-2032) & (US$ Million) Figure 59. North America Organic Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Organic Infant Formula Revenue (2021-2032) & (US$ Million) Figure 61. Europe Organic Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Organic Infant Formula Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Organic Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Organic Infant Formula Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Organic Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Organic Infant Formula Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Organic Infant Formula Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Wet Process Type
  • Dry Process Type
  • Others
Applications
  • First Stage
  • Second Stage
  • Third Stage
Companies covered
  • Abbott
  • HiPP
  • Holle
  • Bellamy
  • Topfer
  • Supermum
  • The Hain Celestial Group
  • Nature One
  • Perrigo
  • Babybio
  • Gittis
  • Humana
  • Bimbosan
  • Ausnutria
  • Nutribio
  • HealthyTimes
  • Arla
  • Angisland
  • Yeeper
  • Wyeth
  • Kendamil
  • Nestle
  • Feihe
  • JUNLEBAO
  • YILI
  • BIOSTIME
  • Biobim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Organic Infant Formula Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Organic Infant Formula Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Organic Infant Formula Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Organic Infant Formula Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Organic Infant Formula Market Dynamics
  1. 2.1 Organic Infant Formula Industry Trends
  2. 2.2 Organic Infant Formula Industry Drivers
  3. 2.3 Organic Infant Formula Industry Opportunities and Challenges
  4. 2.4 Organic Infant Formula Industry Restraints
3 Organic Infant Formula Market by Manufacturers
  1. 3.1 Global Organic Infant Formula Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Organic Infant Formula Sales by Manufacturers (2021-2026)
  3. 3.3 Global Organic Infant Formula Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Organic Infant Formula Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Organic Infant Formula Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Organic Infant Formula Manufacturers, Product Type & Application
  7. 3.7 Global Organic Infant Formula Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Organic Infant Formula Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Organic Infant Formula Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Organic Infant Formula Tier 1, Tier 2, and Tier 3
4 Organic Infant Formula Market by Type
  1. 4.1 Organic Infant Formula Type Introduction
  2. 4.1.1 Wet Process Type
  3. 4.1.2 Dry Process Type
  4. 4.1.3 Others
  5. 4.2 Global Organic Infant Formula Sales by Type
  6. 4.2.1 Global Organic Infant Formula Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Organic Infant Formula Sales by Type (2021-2032)
  8. 4.2.3 Global Organic Infant Formula Sales Market Share by Type (2021-2032)
  9. 4.3 Global Organic Infant Formula Revenue by Type
  10. 4.3.1 Global Organic Infant Formula Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Organic Infant Formula Revenue by Type (2021-2032)
  12. 4.3.3 Global Organic Infant Formula Revenue Market Share by Type (2021-2032)
5 Organic Infant Formula Market by Application
  1. 5.1 Organic Infant Formula Application Introduction
  2. 5.1.1 First Stage
  3. 5.1.2 Second Stage
  4. 5.1.3 Third Stage
  5. 5.2 Global Organic Infant Formula Sales by Application
  6. 5.2.1 Global Organic Infant Formula Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Organic Infant Formula Sales by Application (2021-2032)
  8. 5.2.3 Global Organic Infant Formula Sales Market Share by Application (2021-2032)
  9. 5.3 Global Organic Infant Formula Revenue by Application
  10. 5.3.1 Global Organic Infant Formula Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Organic Infant Formula Revenue by Application (2021-2032)
  12. 5.3.3 Global Organic Infant Formula Revenue Market Share by Application (2021-2032)
6 Global Organic Infant Formula Sales by Region
  1. 6.1 Global Organic Infant Formula Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Organic Infant Formula Sales by Region (2021-2032)
  3. 6.2.1 Global Organic Infant Formula Sales by Region (2021-2026)
  4. 6.2.2 Global Organic Infant Formula Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Organic Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Organic Infant Formula Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Organic Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Organic Infant Formula Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Organic Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Organic Infant Formula Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Organic Infant Formula Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Organic Infant Formula Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Organic Infant Formula Revenue by Region
  1. 7.1 Global Organic Infant Formula Revenue by Region
  2. 7.1.1 Global Organic Infant Formula Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Organic Infant Formula Revenue by Region (2021-2026)
  4. 7.1.3 Global Organic Infant Formula Revenue by Region (2027-2032)
  5. 7.1.4 Global Organic Infant Formula Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Organic Infant Formula Revenue (2021-2032)
  8. 7.2.2 North America Organic Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Organic Infant Formula Revenue (2021-2032)
  11. 7.3.2 Europe Organic Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Organic Infant Formula Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Organic Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Organic Infant Formula Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Organic Infant Formula Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Organic Infant Formula Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 HiPP
  8. 8.2.1 HiPP Company Information
  9. 8.2.2 HiPP Business Overview
  10. 8.2.3 HiPP Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 HiPP Organic Infant Formula Product Portfolio
  12. 8.2.5 HiPP Recent Developments
  13. 8.3 Holle
  14. 8.3.1 Holle Company Information
  15. 8.3.2 Holle Business Overview
  16. 8.3.3 Holle Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Holle Organic Infant Formula Product Portfolio
  18. 8.3.5 Holle Recent Developments
  19. 8.4 Bellamy
  20. 8.4.1 Bellamy Company Information
  21. 8.4.2 Bellamy Business Overview
  22. 8.4.3 Bellamy Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bellamy Organic Infant Formula Product Portfolio
  24. 8.4.5 Bellamy Recent Developments
  25. 8.5 Topfer
  26. 8.5.1 Topfer Company Information
  27. 8.5.2 Topfer Business Overview
  28. 8.5.3 Topfer Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Topfer Organic Infant Formula Product Portfolio
  30. 8.5.5 Topfer Recent Developments
  31. 8.6 Supermum
  32. 8.6.1 Supermum Company Information
  33. 8.6.2 Supermum Business Overview
  34. 8.6.3 Supermum Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Supermum Organic Infant Formula Product Portfolio
  36. 8.6.5 Supermum Recent Developments
  37. 8.7 The Hain Celestial Group
  38. 8.7.1 The Hain Celestial Group Company Information
  39. 8.7.2 The Hain Celestial Group Business Overview
  40. 8.7.3 The Hain Celestial Group Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 The Hain Celestial Group Organic Infant Formula Product Portfolio
  42. 8.7.5 The Hain Celestial Group Recent Developments
  43. 8.8 Nature One
  44. 8.8.1 Nature One Company Information
  45. 8.8.2 Nature One Business Overview
  46. 8.8.3 Nature One Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nature One Organic Infant Formula Product Portfolio
  48. 8.8.5 Nature One Recent Developments
  49. 8.9 Perrigo
  50. 8.9.1 Perrigo Company Information
  51. 8.9.2 Perrigo Business Overview
  52. 8.9.3 Perrigo Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Perrigo Organic Infant Formula Product Portfolio
  54. 8.9.5 Perrigo Recent Developments
  55. 8.10 Babybio
  56. 8.10.1 Babybio Company Information
  57. 8.10.2 Babybio Business Overview
  58. 8.10.3 Babybio Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Babybio Organic Infant Formula Product Portfolio
  60. 8.10.5 Babybio Recent Developments
  61. 8.11 Gittis
  62. 8.11.1 Gittis Company Information
  63. 8.11.2 Gittis Business Overview
  64. 8.11.3 Gittis Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Gittis Organic Infant Formula Product Portfolio
  66. 8.11.5 Gittis Recent Developments
  67. 8.12 Humana
  68. 8.12.1 Humana Company Information
  69. 8.12.2 Humana Business Overview
  70. 8.12.3 Humana Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Humana Organic Infant Formula Product Portfolio
  72. 8.12.5 Humana Recent Developments
  73. 8.13 Bimbosan
  74. 8.13.1 Bimbosan Company Information
  75. 8.13.2 Bimbosan Business Overview
  76. 8.13.3 Bimbosan Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bimbosan Organic Infant Formula Product Portfolio
  78. 8.13.5 Bimbosan Recent Developments
  79. 8.14 Ausnutria
  80. 8.14.1 Ausnutria Company Information
  81. 8.14.2 Ausnutria Business Overview
  82. 8.14.3 Ausnutria Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Ausnutria Organic Infant Formula Product Portfolio
  84. 8.14.5 Ausnutria Recent Developments
  85. 8.15 Nutribio
  86. 8.15.1 Nutribio Company Information
  87. 8.15.2 Nutribio Business Overview
  88. 8.15.3 Nutribio Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Nutribio Organic Infant Formula Product Portfolio
  90. 8.15.5 Nutribio Recent Developments
  91. 8.16 HealthyTimes
  92. 8.16.1 HealthyTimes Company Information
  93. 8.16.2 HealthyTimes Business Overview
  94. 8.16.3 HealthyTimes Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 HealthyTimes Organic Infant Formula Product Portfolio
  96. 8.16.5 HealthyTimes Recent Developments
  97. 8.17 Arla
  98. 8.17.1 Arla Company Information
  99. 8.17.2 Arla Business Overview
  100. 8.17.3 Arla Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Arla Organic Infant Formula Product Portfolio
  102. 8.17.5 Arla Recent Developments
  103. 8.18 Angisland
  104. 8.18.1 Angisland Company Information
  105. 8.18.2 Angisland Business Overview
  106. 8.18.3 Angisland Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Angisland Organic Infant Formula Product Portfolio
  108. 8.18.5 Angisland Recent Developments
  109. 8.19 Yeeper
  110. 8.19.1 Yeeper Company Information
  111. 8.19.2 Yeeper Business Overview
  112. 8.19.3 Yeeper Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Yeeper Organic Infant Formula Product Portfolio
  114. 8.19.5 Yeeper Recent Developments
  115. 8.20 Wyeth
  116. 8.20.1 Wyeth Company Information
  117. 8.20.2 Wyeth Business Overview
  118. 8.20.3 Wyeth Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Wyeth Organic Infant Formula Product Portfolio
  120. 8.20.5 Wyeth Recent Developments
  121. 8.21 Kendamil
  122. 8.21.1 Kendamil Company Information
  123. 8.21.2 Kendamil Business Overview
  124. 8.21.3 Kendamil Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Kendamil Organic Infant Formula Product Portfolio
  126. 8.21.5 Kendamil Recent Developments
  127. 8.22 Nestle
  128. 8.22.1 Nestle Company Information
  129. 8.22.2 Nestle Business Overview
  130. 8.22.3 Nestle Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Nestle Organic Infant Formula Product Portfolio
  132. 8.22.5 Nestle Recent Developments
  133. 8.23 Feihe
  134. 8.23.1 Feihe Company Information
  135. 8.23.2 Feihe Business Overview
  136. 8.23.3 Feihe Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Feihe Organic Infant Formula Product Portfolio
  138. 8.23.5 Feihe Recent Developments
  139. 8.24 JUNLEBAO
  140. 8.24.1 JUNLEBAO Company Information
  141. 8.24.2 JUNLEBAO Business Overview
  142. 8.24.3 JUNLEBAO Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 JUNLEBAO Organic Infant Formula Product Portfolio
  144. 8.24.5 JUNLEBAO Recent Developments
  145. 8.25 YILI
  146. 8.25.1 YILI Company Information
  147. 8.25.2 YILI Business Overview
  148. 8.25.3 YILI Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 YILI Organic Infant Formula Product Portfolio
  150. 8.25.5 YILI Recent Developments
  151. 8.26 BIOSTIME
  152. 8.26.1 BIOSTIME Company Information
  153. 8.26.2 BIOSTIME Business Overview
  154. 8.26.3 BIOSTIME Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  155. 8.26.4 BIOSTIME Organic Infant Formula Product Portfolio
  156. 8.26.5 BIOSTIME Recent Developments
  157. 8.27 Biobim
  158. 8.27.1 Biobim Company Information
  159. 8.27.2 Biobim Business Overview
  160. 8.27.3 Biobim Organic Infant Formula Sales, Price, Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Biobim Organic Infant Formula Product Portfolio
  162. 8.27.5 Biobim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Organic Infant Formula Value Chain Analysis
  2. 9.1.1 Organic Infant Formula Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Organic Infant Formula Production Mode & Process
  6. 9.2 Organic Infant Formula Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Organic Infant Formula Distributors
  9. 9.2.3 Organic Infant Formula Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research